Table 2 Primary treatment outcomes
Treatment outcome | AL, n = 333 (%) | ASAQ, n = 327 (%) | Difference (95 % CI) | P-value |
|---|---|---|---|---|
PCR unadjusted | ||||
ACPR | 159 (47.8) | 219 (67.0) | −0.19 (−26.62; −11.81) | <0.00001 |
TTF | 174 (52.2) | 108 (43.0) | ||
ETF | 2 (0.6) | 3 (0.9) | ||
LCF | 47 (14.1) | 18 (5.5) | ||
LPF | 125 (37.5) | 87 (26.6) | ||
PCR adjusted | ||||
ACPR | 259 (77.8) | 275 (84.1) | −6.32 (−12.29; −0.34) | 0.0389 |
TTF | 74 (22.2) | 52 (15.9) | ||
ETF | 2 (0.6) | 3 (0.9) | ||
LCF | 22 (6.6) | 11 (3.4) | ||
LPF | 50 (15.0) | 38 (11.6) | ||